PTC Therapeutics
PTCT
#2687
Rank
HK$51.21 B
Marketcap
HK$617.38
Share price
0.31%
Change (1 day)
54.67%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$23.90 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are HK$23.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$24.15 B10.98%
2024-12-31HK$21.76 B2.66%
2023-12-31HK$21.19 B32.17%
2022-12-31HK$16.03 B6.21%
2021-12-31HK$15.10 B12.84%
2020-12-31HK$13.38 B66.92%
2019-12-31HK$8.01 B33.22%
2018-12-31HK$6.01 B227.47%
2017-12-31HK$1.83 B58.24%
2016-12-31HK$1.16 B7.58%
2015-12-31HK$1.07 B300.49%
2014-12-31HK$0.26 B126.3%
2013-12-31HK$0.11 B-52.37%
2012-12-31HK$0.25 B-88.61%
2011-12-31HK$2.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
HK$623.88 B 2,510.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
HK$55.82 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$1.88 B-92.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$13.11 B-45.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$0.85 B-96.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$2.11 B-91.16%๐Ÿ‡บ๐Ÿ‡ธ USA